Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Century Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/29/2023 |
4
| Carlo Rizzuto (Director) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 44,000 options to buy
@ $3.19, valued at
$140.4k
|
|
| 06/29/2023 |
4
| Riva Alessandro (Director) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 44,000 options to buy
@ $3.19, valued at
$140.4k
|
|
| 06/29/2023 |
4
| JIMENEZ JOSEPH (Director) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 44,000 options to buy
@ $3.19, valued at
$140.4k
|
|
| 06/29/2023 |
4
| BUTITTA CYNTHIA M (Director) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 44,000 options to buy
@ $3.19, valued at
$140.4k
|
|
| 06/29/2023 |
4
| Blackwell Kimberly (Director) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 44,000 options to buy
@ $3.19, valued at
$140.4k
|
|
| 06/29/2023 |
4
| Quimi Daphne (Director) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 44,000 options to buy
@ $3.19, valued at
$140.4k
|
|
| 06/29/2023 |
4
| Walbert Timothy P (Director) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 44,000 options to buy
@ $3.19, valued at
$140.4k
|
|
| 05/17/2023 |
4
| Carr Douglas (SVP Finance & Operations) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 120,846 shares
@ $0 |
|
| 05/17/2023 |
4
| Diem Michael Craig (CFO) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 151,058 shares
@ $0 |
|
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2023 |
4
| Borges Luis (Chief Scientific Officer) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Exercised 7,452 options to buy
@ $1.03, valued at
$7.7k
|
|
| 03/23/2023 |
4
| Borges Luis (Chief Scientific Officer) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Sold 63,616 shares
@ $3.7706, valued at
$239.9k
Sold 65,698 shares
@ $3.7237, valued at
$244.6k
Sold 15,597 shares
@ $3.55, valued at
$55.4k
Exercised 63,616 options to buy
@ $1.03, valued at
$65.5k
Exercised 65,698 options to buy
@ $1.03, valued at
$67.7k
Exercised 220,930 options to buy
@ $1.03, valued at
$227.6k
|
|
| 02/06/2023 |
4
| Flores Osvaldo (CEO) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 637,500 options to buy
@ $4.64, valued at
$3M
|
|
| 02/06/2023 |
4
| Carr Douglas (VP Finance & Operations) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 7,500 shares
@ $0
Granted 45,000 options to buy
@ $4.64, valued at
$208.8k
|
|
| 02/06/2023 |
4
| Russotti Gregory (Chief Technology Officer) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 175,000 options to buy
@ $4.64, valued at
$812k
|
|
| 02/06/2023 |
4
| Borges Luis (Chief Scientific Officer) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 21,875 shares
@ $0
Granted 131,250 options to buy
@ $4.64, valued at
$609k
|
|
| 02/06/2023 |
4
| Farid Adrienne (Chief Operations Officer) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 21,875 shares
@ $0
Granted 131,250 options to buy
@ $4.64, valued at
$609k
|
|
| 02/06/2023 |
4
| Diem Michael Craig (Chief Business Officer) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 21,875 shares
@ $0
Granted 131,250 options to buy
@ $4.64, valued at
$609k
|
|
| 10/03/2022 |
4
| Quimi Daphne (Director) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 39,744 options to buy
@ $9.89, valued at
$393.1k
|
|
| 10/03/2022 |
4
| Walbert Timothy P (Director) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 39,744 options to buy
@ $9.89, valued at
$393.1k
|
|
| 08/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Riva Alessandro (Director) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 19,872 options to buy
@ $8.56, valued at
$170.1k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Disposed of 178,996 shares
@ $0 |
|
| 01/27/2022 |
4
| Diem Michael Craig (Chief Business Officer) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 105,000 options to buy
@ $13.15, valued at
$1.4M
|
|
| 01/27/2022 |
4
| Farid Adrienne (Chief Operations Officer) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 105,000 options to buy
@ $13.15, valued at
$1.4M
|
|
| 01/27/2022 |
4
| Borges Luis (Chief Scientific Officer) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 105,000 options to buy
@ $13.15, valued at
$1.4M
|
|
| 01/27/2022 |
4
| Levitsky Hyam (President of R&D) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 105,000 options to buy
@ $13.15, valued at
$1.4M
|
|
| 01/27/2022 |
4
| Russotti Gregory (Chief Technology Officer) has filed a Form 4 on Century Therapeutics, Inc.|
Txns:
| Granted 105,000 options to buy
@ $13.15, valued at
$1.4M
|
|
|
|
|